Foundation Fighting Blindness Retinal Degeneration Fundinsider trades
In SEC Form 4 filings, Foundation Fighting Blindness Retinal Degeneration Fund is listed as Director of Opus Genetics, Inc. (IRD). In the last 90 days, Foundation Fighting Blindness Retinal Degeneration Fund sold $2.76M of Opus Genetics, Inc. (IRD) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IRDOpus Genetics, Inc. | Director | 1 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-02
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.